Señales en vivo de HUGE | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	26.79M
Volumen promedio	518 809
Capitalización de mercado	6.55M
EPS	$-0.0431 ( Q4 \| 2024-04-02 )
Próxima fecha de ganancias	( $-0.0600 ) 2024-07-18
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.650 (Sector) 42.63 (Industry) 0
ATR14	$0.00200 (1.23%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX -1.40%

AKAN -3.75%

ALIM 0.54%

AMPH -0.87%

AMYT 0.00%

ANIP 0.94%

AQST 0.39%

ASRT -5.34%

ATNX 0.00%

AVDL -1.75%

AYTU 0.00%

BFRI -2.39%

BGXX -34.22%

CLVR -2.22%

COLL -0.74%

CPIX 0.66%

CRDL 1.00%

CRON -0.43%

CYTH 5.83%

DCPH 0.00%

DERM 9.73%

DRRX -5.49%

DVAX -1.23%

EGRX 11.55%

EMBC 0.32%

EMBCV -9.33%

EOLS -0.73%

ESPR -3.90%

EVOK 5.48%

FLGC 6.71%

FLXN 0.00%

GHSI -0.35%

HCM -1.83%

HROW -0.52%

HUGE -4.71%

IMCC 2.20%

INCR 2.03%

IRWD 5.16%

ITCI -3.51%

IXHL 10.53%

JUPW 11.76%

KALA 9.92%

KIN 0.11%

KMDA -1.78%

LNTH -1.25%

NBIX 2.50%

NEPT 0.00%

NLTX 1.45%

OGI -3.75%

OPTN -3.70%

ORGO 6.06%

PAHC -2.50%

PCRX 2.51%

PETQ -0.45%

PLXP 0.00%

PPD 0.00%

PROC -0.40%

PRPH -2.11%

PTPI 2.69%

RDHL -2.58%

RDUS 4.30%

REPH -0.48%

RGC -5.88%

RMTI 0.00%

SCTL 0.92%

SCYX -1.48%

SIGA 3.13%

SISI -13.33%

SNDL -1.04%

SNOA 1.05%

SSIC 1.03%

SUPN -0.45%

SXTC -2.24%

THTX 0.00%

TKNO -1.44%

TLGT -13.85%

TLRY -4.05%

TXMD -7.47%

TYHT -3.90%

UPC -1.97%

VTRS 1.43%

ZYNE 2.36%

Correlación (AI algo v.1.1b): Overvalued: -0.03% $0.162 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.48 (neutral)

Corto: 0.08 (neutral)

Signal:(48.126) Neutral

FSD Pharma Inc Correlación

10 Correlaciones Más Positivas
APDN	0.961
APVO	0.957
SHLS	0.956
ALLR	0.952
GLPG	0.951
ALGT	0.949
MBIO	0.945
LGHL	0.942
JACK	0.942
IART	0.94

10 Correlaciones Más Negativas
AEYE	-0.952
VCTR	-0.949
IVCB	-0.944
SMTC	-0.941
NKTR	-0.939
VITL	-0.937
GDST	-0.937
GGAL	-0.936
USAP	-0.929
JAN	-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

FSD Pharma Inc Correlación - Moneda/Commodity

-0.20
( neutral )

-0.02
( neutral )

0.00
( neutral )

0.54
( weak )

FSD Pharma Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-2.55M (0.00 %)
EPS:	$-0.470

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-2.55M (0.00 %)
EPS:	$-0.470

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-4.36M (0.00 %)
EPS:	$-0.600

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.010

Financial Reports:

No articles found.

FSD Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

FSD Pharma Inc

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.